The Future of Affordable Fertility Care with Conceivable Life Sciences

IVF is a life-changing option for many hoping to start a family, but high costs and limited accessibility often make it unattainable for many. In this episode, we delve into how Conceivable Life Sciences, a groundbreaking Muse Capital portfolio company, is transforming the IVF landscape by leveraging robotics and AI to automate critical parts of the IVF process, making it more affordable, accessible, and effective.   Co-founder Joshua Abram shares his vision for democratizing fertility care through cutting-edge automation and innovative technology. By focusing on robotic precision and AI-driven insights, Conceivable’s fully automated labs streamline traditionally manual and error-prone processes, reducing IVF costs from $75,000 to $15,000 and turning the dream of parenthood into a reality for millions.   In this episode, you’ll hear: The historical journey of IVF, from its inception in 1978 to today's advancements. How Conceivable’s fully automated labs are redefining success rates, reducing variability, and improving outcomes. The role of automation in addressing the current barriers to IVF accessibility. Insights into why fertility care has failed to scale and how Conceivable is creating a population health-based solution. Stories of patients and partners embracing these innovations to overcome infertility challenges. The future of IVF, including policy changes and the broader societal implications of making fertility care universally accessible.   Whether you're navigating infertility or interested in the intersection of healthcare and innovation, this episode sheds light on how technology is reshaping one of the most personal and transformative aspects of human life.   Tune in to learn how Conceivable is setting a new gold standard for IVF and fertility care.   To find out more about Muse Capital go to www.musecapital.vc